Article

Excimer laser installed at two institutions

Boston-The Massachusetts Eye and Ear Infirmary, a teaching affiliate of Harvard Medical School, was the first institution in the United States to acquire the Allegretto Wave Eye-Q excimer laser system for performing LASIK. Another system was installed 2 weeks later at Emory Vision, part of the Emory Eye Center and the Emory School of Medicine, Atlanta.

Boston-The Massachusetts Eye and Ear Infirmary, a teaching affiliate of Harvard Medical School, was the first institution in the United States to acquire the Allegretto Wave Eye-Q excimer laser system for performing LASIK. Another system was installed 2 weeks later at Emory Vision, part of the Emory Eye Center and the Emory School of Medicine, Atlanta.

The device, sold by WaveLight Inc., can correct 1 D of myopia or hyperopia in 2 seconds, the company said, with an average treatment time of 8 to 10 seconds. It has a repetition rate of 400 Hz, compared with the 200-Hz Allegretto Wave system.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.